BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 35813296)

  • 1. Oridonin represses epithelial-mesenchymal transition and angiogenesis of thyroid cancer via downregulating JAK2/STAT3 signaling.
    Liu W; Wang X; Wang L; Mei Y; Yun Y; Yao X; Chen Q; Zhou J; Kou B
    Int J Med Sci; 2022; 19(6):965-974. PubMed ID: 35813296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pterostilbene suppresses gastric cancer proliferation and metastasis by inhibiting oncogenic JAK2/STAT3 signaling: In vitro and in vivo therapeutic intervention.
    He P; Li Y; Hu J; Deng B; Tan Z; Chen Y; Yu B; Dong W
    Phytomedicine; 2024 Jun; 128():155316. PubMed ID: 38518635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of SOCS2 Inhibits EMT and M2 Macrophage Polarization in Cervical Cancer
    Li D; Huang Y; Wei M; Chen B; Lu Y
    Comb Chem High Throughput Screen; 2024; 27(7):984-995. PubMed ID: 37594110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sciellin promotes the development and progression of thyroid cancer through the JAK2/STAT3 signaling pathway.
    Guo H; Wang Z; Yin K; Ma R; Zhang Y; Yin F; Li H; Yin D
    Mol Carcinog; 2024 Apr; 63(4):701-713. PubMed ID: 38411346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of JAK2/STAT3 Pathway by Notoginsenoside R1 Reduces Epithelial-Mesenchymal Transition in Non-small Cell Lung Cancer.
    Wan M; Yu H; Zhai H
    Mol Biotechnol; 2024 Apr; ():. PubMed ID: 38565774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural compound Byakangelicin suppresses breast tumor growth and motility by regulating SHP-1/JAK2/STAT3 signal pathway.
    Shi X; Lai Y; Liu W; Zhang X; Cang Y
    Biochem Biophys Res Commun; 2024 Apr; 706():149758. PubMed ID: 38484571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An Insight into the Anti-Angiogenic and Anti-Metastatic Effects of Oridonin: Current Knowledge and Future Potential.
    Abdullah NA; Md Hashim NF; Ammar A; Muhamad Zakuan N
    Molecules; 2021 Feb; 26(4):. PubMed ID: 33546106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of JAK-STAT signaling pathway mediated by CXCL8 gene silencing on epithelial-mesenchymal transition of human cutaneous melanoma cells.
    Hu X; Yuan L; Ma T
    Oncol Lett; 2020 Aug; 20(2):1973-1981. PubMed ID: 32724443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metochalcone induces senescence-associated secretory phenotype via JAK2/STAT3 pathway in breast cancer.
    Zhou J; Wan F; Xiao B; Li X; Peng C; Peng FU
    Oncol Res; 2024; 32(5):943-953. PubMed ID: 38686052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of STAT3 in cancer cell epithelial‑mesenchymal transition (Review).
    Zhang G; Hou S; Li S; Wang Y; Cui W
    Int J Oncol; 2024 May; 64(5):. PubMed ID: 38488027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epithelial IL5RA promotes epithelial-mesenchymal transition in pulmonary fibrosis via Jak2/STAT3 cascade.
    Chen S; Zhao T; Xie S; Wan X
    Pulm Pharmacol Ther; 2024 Mar; 84():102286. PubMed ID: 38191068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioactive Ent-Kaurane Diterpenes Oridonin and Irudonin Prevent Cancer Cells Migration by Interacting with the Actin Cytoskeleton Controller Ezrin.
    Pagliara V; Donadio G; De Tommasi N; Amodio G; Remondelli P; Moltedo O; Dal Piaz F
    Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 33003361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrating Epigenetics, Proteomics, and Metabolomics to Reveal the Involvement of Wnt/β-Catenin Signaling Pathway in Oridonin-Induced Reproductive Toxicity.
    Wu Q; Gao X; Lin Y; Wu C; Zhang J; Chen M; Wen J; Wu Y; Tian K; Bao W; Sun P; Zhu A
    Toxics; 2024 May; 12(5):. PubMed ID: 38787118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oridonin from
    Ali MA; Khan N; Ali A; Akram H; Zafar N; Imran K; Khan T; Khan K; Armaghan M; Palma-Morales M; Rodríguez-Pérez C; Caunii A; Butnariu M; Habtemariam S; Sharifi-Rad J
    Food Sci Nutr; 2024 May; 12(5):3046-3067. PubMed ID: 38726411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erratum: Roche, J. The Epithelial-to-Mesenchymal Transition in Cancer. Cancers, 2018, 10, 52.
    Roche J
    Cancers (Basel); 2018 Mar; 10(3):. PubMed ID: 29562660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oridonin promotes endoplasmic reticulum stress via TP53-repressed TCF4 transactivation in colorectal cancer.
    Zhou F; Gao H; Shang L; Li J; Zhang M; Wang S; Li R; Ye L; Yang S
    J Exp Clin Cancer Res; 2023 Jun; 42(1):150. PubMed ID: 37337284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent advances in oridonin derivatives with anticancer activity.
    Sobral PJM; Vicente ATS; Salvador JAR
    Front Chem; 2023; 11():1066280. PubMed ID: 36846854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oridonin supplementation in rabbits may help to improve the outcome of induced atherosclerosis via autophagy induction.
    Sultan A; Mohammad B; Hadi N; Al-Shaibany A; Philip A; Jamil D; Al-Aubaidy H
    Acta Biomed; 2023 Apr; 94(2):e2023015. PubMed ID: 37092629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oridonin Induces Apoptosis in Esophageal Squamous Cell Carcinoma by Inhibiting Cytoskeletal Protein LASP1 and PDLIM1.
    Zhang X; Xing M; Ma Y; Zhang Z; Qiu C; Wang X; Zhao Z; Ji Z; Zhang JY
    Molecules; 2023 Jan; 28(2):. PubMed ID: 36677861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oridonin attenuates lung inflammation and fibrosis in silicosis via covalent targeting iNOS.
    Gao J; Li C; Wang X; Sun X; Zhang R; Chen C; Yu M; Liu Y; Zhu Y; Chen J
    Biomed Pharmacother; 2022 Sep; 153():113532. PubMed ID: 36076611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.